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Abstract To determine the relationship between gastric
function and upper abdominal sensations we studied sixty
FD patients (43 female). All patients underwent three
gastric function tests:
13C octanoic gastric emptying test,
three-dimensional ultrasonography (proximal and distal
gastric volume), and the nutrient drink test. Upper
abdominal sensations experienced in daily life were scored
using questionnaires. Impaired proximal gastric relaxation
(23%) and a delayed gastric emptying (33%) are highly
prevalent in FD patients; however, only a small overlap
exists between the two pathophysiologic disorders (5%).
No relationship was found between chronic upper
abdominal symptoms and gastric function (proximal gas-
tric relaxation, gastric emptying rate, or drinking capacity)
(all P[0.01). Proximal gastric relaxation or gastric
emptying rate had no effect on maximum drinking capacity
(P[0.01). The lack of relationship between chronic upper
abdominal sensations and gastric function questions the
role of these pathophysiologic mechanisms in the genera-
tion of symptoms.
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Introduction
Functional dyspepsia (FD) is a common disorder seen in
daily clinical practice, characterized by the presence of
pain or discomfort in the upper abdomen in the absence of
organic, systemic, or metabolic disease [1]. Functional
dyspeptic patients complain about a variety of symptoms,
which are frequently intermittent, and mostly related to
food intake [2]. For that reason, a subdivision of patients
has been proposed, in order to clarify the heterogeneity of
this disorder and to direct treatment options [3]. Attempts
have been made to subdivide patients according to their
symptoms; however, a large overlap of symptoms exists
and many patients do not ﬁt into one of the subgroups [1].
Currently, many efforts are being made to subdivide
patients according to gastric (dys)function, and to ﬁnd new
ways of treating these proposed pathophysiologic disorders
[4]. Three pathophysiologic mechanisms have been
described as possible etiologic factors: (1) a delayed gastric
emptying, (2) impaired proximal gastric accommodation,
and (3) visceral hypersensitivity. Delayed gastric emptying
is present in approximately 30% of FD patients, and may
be one of the underlying mechanisms for symptoms
(vomiting and postprandial fullness) [5]. Impaired proxi-
mal gastric relaxation may be an important etiologic factor
in the pathophysiology of functional dyspepsia, consider-
ing the high prevalence of approximately 40% in FD
patients, and a possible association with early satiety,
weight loss, and fullness [6, 7]. Finally, an increased
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even though difﬁcult to measure, an important etiologic
factor in the pathophysiology of FD [8]. However, when
targeting speciﬁc pathophysiologic mechanisms by the use
of pharmacologic agents, the effect on symptoms is ques-
tionable [6, 9, 10]. In other words, the relationship between
speciﬁc upper abdominal sensations and the above-men-
tioned mechanisms remains to be matter of debate.
We conducted a study to assess the relationship between
gastric function and upper abdominal sensations. Gastric
emptying rate, proximal gastric relaxation, and maximum
drinking capacity were assessed in FD patients. The
symptoms experienced in daily life (chronic upper
abdominal symptoms) were assessed and related to the
primary outcome parameters of the gastric function tests.
We hypothesised that chronic upper abdominal symptoms
and speciﬁc pathophysiologic mechanisms have no corre-
lation in functional dyspepsia.
Materials and methods
Patients
All patients visiting the outpatient clinics at our hospital,
fulﬁlling the Rome II criteria for functional dyspepsia [1],
were subjected to three non-invasive functional tests of the
stomach. A total of 60 functional dyspeptic patients were
prospectively evaluated; 43 female (median age 40 years;
range 18–65) and 17 male (median age 37 years; range
21–64).
The inclusion criteria were (a) the presence of dyspeptic
symptoms, assessed using the questionnaire described
below; (b) no evidence of macroscopic inﬂammation of the
esophageal mucosa or focal lesions of the esophagogas-
troduodenal mucosa at upper gastrointestinal endoscopy
(performed within 1-year prior to inclusion); (c) no abnor-
malities seen during upper abdominal ultrasonography
(performed within 1 year prior to inclusion); (d) absence of
serious concomitant illness; and (e) the absence of major
gastrointestinal surgery (excluding appendectomy).
The protocol was approved by the ethics committee of
the University Medical Center Utrecht. All patients gave
written informed consent for inclusion in the trial.
Chronic dyspeptic symptoms questionnaire
Each patient completed a reproducible dyspepsia ques-
tionnaire [5, 6, 11]. Patients were asked to score six
different symptoms (pain or discomfort centered in the
upper abdomen, early satiety, bloating in the upper
abdomen, fullness, nausea, and vomiting) from 0 to 5
(0 = none, 1 = very mild; awareness of symptoms but
easily tolerated, 2 = mild; tolerated without interference
with usual activity, 3 = moderate; enough to cause some
interference with usual activity, 4 = severe; enough to
cause signiﬁcant interference with usual activity, 5 = very
severe; incapacitating with inability to work or do usual
activity). For inclusion, two of these symptoms had to be
scored as moderate, severe or very severe and these
symptoms needed to be present for at least 12 weeks, not
necessary consecutive, in the preceding 12 months.
Study protocol
All patients underwent three functional tests of the stomach
on three separate days; the
13C-octanoic breath test, three-
dimensional ultrasonography of the stomach, and a nutrient
drink test. The order of the three study days was arbitrary.
Each of the study days started at 08:00 h after an overnight
fast of at least 10 h. The time interval between the tests was
three days to 2 weeks. Patients were asked to discontinue
any medication known to inﬂuence gastrointestinal motility
or sensitivity for at least 7 days prior to the study,
including PPI therapy. The use of narcotics, anticholinergic
medication, serotonergic medication (including selective
serotonin reuptake inhibitors), and antidepressants was
considered an exclusion criterion. None of the patients
were on NSAID therapy.
13C-octanoic breath test
The rate of gastric emptying was assessed using the
13C-
octanoic breath test. The test meal consisted of two fried
eggs, one slice of bread, 5 g margarine and 150 ml water
(total caloric value of 294 kcal and a nutrient composition
of 16 g protein, 16 g carbohydrate, 18 g fat) [12]. The egg
yolk of one egg was labelled with 100 mg
13C-sodium-
octanoic acid (598 lmol; Campro Scientiﬁc, Veenendaal,
The Netherlands), dissolved in 1 ml distilled water. Breath
samples were taken at baseline, before the meal and from
start of ingestion of the meal every 2 min the ﬁrst 30 min,
every 5 min for the next 30 min and every 15 min there-
after up to 4 h.
Three-dimensional ultrasonography
Total-, proximal-, and distal gastric volumes were assessed
before and after ingestion of a nutrient drink using 3D-US
[13–16]. Ultrasonographic data were acquired in a sitting
position, while fasting and at 5, 15, 30, 45, and 60 min
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(500 ml) consisted of 200 ml lactose- and ﬁber-free milk
drink, containing 12.0 g proteins, 11.6 g fat and 36.8 g
carbohydrate (300 kcal) (Nutridrink, Nutricia, Zoetermeer,
The Netherlands) mixed with 300 ml of water, and was
ingested within 3 min.
The 3D imaging system consisted of an ultrasound
scanner with a 3.5 MHz curved probe and a tracking sys-
tem (Esaote-Pie Medical, Maastricht, The Netherlands).
The tracking system consisted of a transmitter generating a
spatially varying magnetic ﬁeld and a small receiver, ﬁrmly
attached to the ultrasound probe, containing three orthog-
onal coils to sense the magnetic ﬁeld strength [17]. A
standardized ultrasound-scanning pattern was used, starting
at the left lateral subcostal margin and then moving distally
towards the pylorus having the probe in a vertical position
[14]. The 2D sagittal planes were used to draw the region
of interest, corresponding to the inner layer of the stomach
wall (the interface between the outer proﬁle of the gastric
wall mucosa and the liquid nutrition). A 3D reconstructed
image of the stomach and the gastric volume was obtained
using software with rendering and volume estimation
capability (In Vivo ScanNT, Medcom GmbH, Darmstadt,
Germany).
The proximal gastric volume was deﬁned as the gastric
volume between the diaphragm and a dividing plane 10 cm
below the point where the fundic top reaches the dia-
phragm. Similarly, a distal part was separated, deﬁned as
the gastric region between the antral area (the sagittal
ultrasound plane in which the antrum, the left liver lobe,
the superior mesenteric vein and the abdominal aorta are
seen simultaneously) and the gastroduodenal junction [18].
At every time point, we subtracted fasting total or partial
gastric volume leaving the change in total or partial gastric
volume. Proximal and distal gastric volume ratios were
calculated by dividing proximal or distal gastric volume by
total gastric volume. Recently, we deﬁned impaired prox-
imal relaxation as the average of the proximal gastric
volume ratios of 5 and 15 min smaller than the lower
limit of the 95% conﬁdence interval (0.32–0.57) of
healthy controls; 35 healthy controls (16 male; mean age
31 (18–53) years) [7]. All measurements were made by a
single investigator (N.v.L.) who was blinded for the results
of the gastric emptying test and the drink test.
Nutrient drink test
The nutrient drink test was used to measure the drinking
capacity and the symptoms evoked by a nutrient drink [19,
20]. Patients were asked to ingest a nutrient drink (Nutri-
drink; 1.5 kcal/ml) at a constant rate of 15 ml/min. At
5-min intervals, they scored satiety using a graphic rating
scale that combines verbal descriptors on a scale graded
0–5 (0 = no satiety, 5 = maximum satiety). The test ends
when the subject reaches maximum satiety. In healthy
controls, maximum satiety occurs after ingestion of
1005 ml (1508 kcal). The lower limit of normal was
653 ml (979 kcal) [19]. In the same study, FD patients
ingested 361 ml (542 kcal) before reaching maximum
satiety.
Statistical analysis
The main focus of our analysis was (a) to analyse a pos-
sible relationship between the rate of gastric emptying,
total or partial gastric volumes after meal ingestion, and
drinking capacity, and (b) to compare the outcome of the
13C-octanoic breath test, the 3D-US test, and the drink test
with the symptoms of patients experienced during daily life
(chronic symptoms).
The primary end points of the gastric function tests are
dichotomous and continuous. The relationship between the
outcomes of the three gastric function tests was studied
using a Pearson’s correlation between continuous variables
(half-emptying time, retentions after 120 min, fasting
gastric volume, proximal gastric volume ratio, distal gastric
volume ratio, and maximum drinking capacity). Secondly,
patients were subdivided in two groups, according to
postprandial proximal gastric relaxation (normal or
impaired), and according to the rate of gastric emptying
(normal or delayed), in order to compare multiple variables
between the sub-groups using the Students’ t-test.
Chronic upper abdominal symptoms (ordinal variables)
were compared between FD patients with normal- or
delayed gastric emptying or a normal or impaired proximal
gastric relaxation (dichotomous variable), using the v
2 test.
Secondly, the relationship between chronic upper abdom-
inal symptoms and half-emptying time, retention after
120 min, fasting gastric volume, proximal gastric volume
ratio, distal gastric volume ratio, and maximum tolerated
volume (continuous variable) was analysed using one-way
analysis of variance (ANOVA).
We have analysed the effect of age, height, weight,
BMI, and sex on the outcome of the gastric function tests
and the chronic symptoms using a regression analysis. All
variables were tested in single models and using multi-
variable analysis.
Due to the high number of comparisons made, we
considered a P value of \0.01 as statistically signiﬁcant.
All statistical analysis was performed using commercially
available software (SPSS 11.0 for Microsoft windows). For
the v
2 test and the Students’ t-test, on the basis of a
Cohen’s effect size of 0.8, a power of 0.80 was obtained
with 60 subjects (considering a = 0.01) [21]. With the
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detect an R value of 0.40 with an a = 0.01.
Results
Combined assessment of the
13C-octanoic breath test, 3D-
US, and the nutrient drink test was performed in 60 FD
patients. The frequency of upper abdominal sensations
scored as moderate or higher was upper abdominal pain
(80%), early satiety (59%), bloating (77%), fullness (71%),
and nausea (51%). Vomiting was present in 13% of
patients (Table 1).
Gastric emptying and proximal gastric relaxation
Figure 1 shows the frequency of a delayed gastric empty-
ing rate, deﬁned as a half emptying time ‡120 min and/or a
retention after 120 min ‡40%, and impaired proximal
gastric relaxation, deﬁned as an average proximal gastric
volume ratio of 5 and 15 min postprandially £ 0.32 (95%
CI healthy controls) in the patient group [7]. A delayed
gastric emptying with a normal proximal gastric relaxation
was found in 33% of patients. Impaired proximal gastric
relaxation with a normal gastric emptying rate was
observed in 23% of patients. In 38% of all patients, none of
both pathophysiologic disorders were found. Finally, only a
small overlap exists between the two pathophysiologic
disorders (5% of patients). These numbers are in concor-
dance with literature [5, 6].
Nutrient drink test
The average amount of nutridrink ingested before reaching
maximum satiety was 399.8 (344–447) ml (600 kcal).
Table 2 summarizes the results of the nutrient drink test.
No effect of age or BMI on MTV and upper abdominal
sensations was observed (all P[0.01). Male patients had a
maximum tolerated volume (MTV) of 500 (381–618), and
female patients of 359 (301–417) (P = 0.017).
Relationship between gastric emptying, total and partial
gastric volume, and drinking capacity
Table 3 displays some of the patient characteristics in FD
patients with normal or impaired proximal gastric relaxa-
tion and with normal or delayed gastric emptying. Age or
BMI did not inﬂuence proximal gastric relaxation or the
rate of gastric emptying. Patients with a normal gastric
emptying rate had an MTV of 439 ml (359–519) whereas
patients with a delayed gastric emptying had a MTV of
334 ml (279–389) (P=0.032). MTV in patients with
normal or impaired proximal relaxation was very similar
(404 and 384 ml respectively). In patients with normal
proximal gastric relaxation, an average fasting gastric
volume of 50 ml (41–59) was determined, opposed to
34 ml (24–44) in patients with impaired proximal relaxa-
tion (P=0.029). The fasting gastric volume in patients
with normal or delayed gastric emptying was 44 and 47 ml,
respectively.
Table 1 Frequency of severity grading for each of six dyspeptic symptoms in 60 dyspeptic patients (chronic symptoms)
0 (None) 1–2 (Very mild–mild) 3 (Moderate) 4–5 (Severe–very severe)
Upper abdominal pain 1 (2) 11 (18) 18 (30) 30 (50)
Early satiety 7 (12) 18 (30) 19 (32) 16 (27)
Bloating 4 (7) 10 (17) 27 (45) 19 (32)
Fullness 2 (3) 15 (25) 26 (43) 17 (28)
Nausea 10 (17) 19 (32) 14 (23) 17 (28)
Vomiting 46 (77) 6 (10) 2 (3) 6 (10)
Numbers in parentheses represent row percentages
5%
38% 33%
23%
Fig. 1 Gastric emptying and proximal gastric relaxation in 60 FD
patients: 33% of patients have a delayed gastric emptying and normal
proximal gastric relaxation (black), 23% of patients have impaired
proximal gastric relaxation and a normal gastric emptying rate
(striped), 38% of patients have none of the pathophysiologic disorders
(white), and 5% of patients have both disorders (grey)
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123Twenty out of 43 female patients had a delayed gastric
emptying (47%) and 18% of all male patients had a delayed
gastric emptying (P=0.038). The prevalence of impaired
proximal gastric relaxation in male and female patients was
21% and 35% respectively (not shown in the table).
A positive correlation was observed between the prox-
imal gastric volume ratio (3D-US) and half emptying time
(r = 0.32, P = 0.015) and the retention after 120 min
(r = 0.30, P = 0.024) (
13C breath test). No correlation was
found between the distal gastric volume ratio and the main
outcome parameters of the gastric emptying test.
Relationship between chronic symptoms and gastric
function
No effect of age, sex, or BMI on any of the chronic upper
abdominal sensations was observed, except that patients
with a higher BMI or a higher weight scored lower on
symptoms of early satiety (both P = 0.007). Figure 2
shows the chronic upper abdominal symptoms in FD
patients with normal or delayed gastric emptying and
normal or impaired proximal gastric relaxation. No dif-
ferences were observed in the percentage of patients who
scored any of the upper abdominal symptoms as moderate
or higher between these groups (all P[0.01). We did not
ﬁnd any correlation between half emptying time, retention
after 120 min, proximal gastric volume ratio, distal gastric
volume ratio, fasting gastric volume, and any of the chronic
upper abdominal symptoms (all P[0.01).
Figure 2 depicts all FD patients categorized according to
their chronic complaints; mild (1–2), moderate (3), and
severe (4–5). No difference in maximum drinking capacity
was observed between the three groups (all P[0.01)
(Fig. 3). Interestingly, patients who reported early satiety
as moderate or higher have a comparable drinking capacity
with patients who do not experience this symptom in daily
life.
Discussion
The following were the most important ﬁndings of this
study: (1) no relationship was found between chronic upper
abdominal symptoms and gastric function (proximal gas-
tric relaxation, gastric emptying rate, or drinking capacity),
(2) a third of all FD patients had a normal gastric emptying
rate and a normal proximal gastric relaxation, and only a
small overlap existed between the two pathophysiologic
disorders (7%), and (3) there was an absence of any
Table 2 The effect of age, BMI, and sex on maximum tolerated volume (MTV) and the change in upper abdominal sensations after the nutrient
drink test
Age BMI Sex
b0 b1 b0 b1 Female Male
MTV 329 (160–499) 1.7 (–2.2–5.6) 363 (3–725) 1.6 (–14 –18) 359 (301–417) 500 (381–618)
Delta symptoms
Pain 11 (0–35) 0.02 (–0.5–0.6) 24 (0–74) -0.5 (–3–2) 10 (0–20) 14 (0–28)
Fullness 49 (23–76) -0.1 (–0.7–0.5) 49 (0–100) -0.1 (–2–2) 48 (37–59) 42 (29–55)
Nausea 46 (20–72) -0.5 (–1–0.1) 28 (0–85) -0.2 (–3–2) 21 (11–31) 31 (12–50)
Hunger –28 (–50–0) 0.09 (–0.4–0.6) –7 (–52–40) –0.8 (–3–1.2) –24 (–33 to –15) –25 (–37 to –14)
b0: intercept of the model. b1: slope of the corresponding variable. Numbers in parenthesis represent the 95% conﬁdence interval of bI. MTV and
delta symptoms in female and male patients are presented as mean (95% conﬁdence interval for mean). No effect of age, BMI, or sex on MTV or
the change in upper abdominal sensations after the nutrient drink test was observed (all P[0.01)
Table 3 Characteristics of FD patients, subdivided according to the extent of proximal gastric relaxation or the rate of gastric emptying (n = 60)
Proximal gastric relaxation Gastric emptying
Normal (n = 43) Impaired (n = 17) Normal (n = 37) Delayed (n = 23)
Age 41 (36–45) 42 (35–49) 40.9 (36–45) 41 (35–48)
BMI 22 (21–23) 23 (21–25) 22 (21–23) 22 (21–23)
MTV (ml) 404 (346–461) 384 (237–530) 439 (359–519) 334 (279–389)
Fasting gastric volume (ml) 50 (41–59) 34 (24–44) 44 (33–55) 47 (37–56)
Data are presented as mean (95% conﬁdence interval for mean). No effect of age and BMI on proximal gastric relaxation or gastric emptying was
observed
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proximal gastric relaxation or gastric emptying rate.
The observation that approximately 40% of FD patients
had a delayed gastric emptying, and approximately 30% of
FD patients had impaired proximal gastric relaxation, is
conﬁrmatory of previous studies [5, 6]. The relative small
overlap between the two pathophysiologic mechanisms
may suggest that one abnormality excludes the other.
However, no signiﬁcant positive correlation between the
proximal gastric volume ratio and half emptying time or
retention after 120 min was found. The rate of gastric
emptying is most likely dependent on many factors,
including fundal, antral, pyloric, and duodenal motility
[22]. For that reason, gastric emptying and postprandial
gastric relaxation should be considered as two separate
mechanisms [23].
For assessment of partial gastric volumes we used
3D-US as a noninvasive alternative for the barostat tech-
nique. Recently, a head-to-head comparison between the
barostat and 3D-US was performed, in which it was shown
that 3D-US was able to identify almost all patients with
impaired accommodation assessed by barostat. It was,
however, emphasized that the two techniques are not
interchangeable, which is likely to be due to the difference
in invasiveness of both techniques. Since there is no
absolute concordance between the two techniques, we must
preserve some reservations in generalizing the results of
the current study.
The nutrient drink test has been suggested as a tool to
measure meal-induced satiety, and as a non-invasive
alternative for the detection of normal- or impaired
accommodation of the stomach [6, 19]. Furthermore, a
positive relationship between the rate of gastric emptying
and the amount of Kcal ingested during the nutrient drink
test has been described, thereby suggesting that the maxi-
mum tolerated volume is not only inﬂuenced by gastric
accommodation [24]. However, many studies have shown
conﬂicting results, displaying no relationship between
drinking capacity and barostat or SPECT ﬁndings, [25, 26]
and a negative relationship between gastric emptying rate
and maximum tolerated volume [27].
Since the results from different studies do not corre-
spond, it remains a mystery what it is we are testing with
the nutrient drink test. The suggestion that the nutrient
drink test can be used to discriminate between FD patients
with normal or impaired visceral sensitivity is disputable
[9]. In the current study, we did not observe any relation-
ship between MTV and chronic upper abdominal
symptoms or between MTV and proximal gastric relaxa-
tion or gastric emptying rate. Most studies do agree that the
drink test differentiates between FD patients and healthy
controls, as we have found in the present study. Notably,
the average amount of nutridrink ingested until maximum
satiety, was very similar to what others have found
(approximately 360 ml) [19], which is below the 95%
conﬁdence interval of healthy controls. No effect of age or
BMI on MTV was observed in the current study, however
we did observe a modest effect of gender, although this did
not reach statistical signiﬁcance (P = 0.017) [20].
The nutrient drink test is also being used in pharmaco-
logical trials, and a resemblance between symptoms
evoked by the meal challenge and symptoms experienced
in daily life has been observed [27]. Recently, we have
performed a double blind, placebo-controlled, crossover
trial, in which the activity of a new drug was tested, using
the outcome of the nutrient drink test as one of the end
points in the study [28]. FD patients who participated in the
pharmacological trial drank signiﬁcantly more compared to
the FD patients in the current study; 569 ± 90 ml and
360 ± 30 ml respectively (P\0.001). A strong placebo
effect and cognitive inﬂuences like motivation should
therefore be considered as confounding factors. No dif-
ferences in age, sex, BMI, chronic symptoms, or upper
abdominal sensations experienced during the drink test
were observed between the patients who participated in the
pharmacological trial and those who did not.
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Fig. 2 Chronic upper abdominal symptoms scored from 0 (nonex-
istent) to 5 (very severe; incapacitating with inability to work or do
usual activity). The ﬁgure shows the number of the patients who
scored three (moderate) or higher on the questionnaire (expressed as a
percentage of the total) in subgroups with; (Fig. 1A) normal- (h)o r
delayed (j) gastric emptying, and (Fig. 1B) normal- (h) or impaired
(j) proximal relaxation
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123In summary, the maximum drinking capacity of FD
patients, seen at a tertiary referral practice, is not inﬂu-
enced by gastric emptying rate or proximal gastric
relaxation. The question is raised what usefulness this test
has, in terms of diagnosis or treatment options, in FD
patients and as a tool to analyze gastric function or upper
abdominal sensations. Since we did not ﬁnd any relation-
ship between upper abdominal symptoms and MTV, the
nutrient drink test cannot be regarded as an alternative for
measuring visceral perception, as can be done by gastric
barostat. In our opinion, many subjective factors, like
motivation, probably play an important disturbing factor in
the outcome of the test.
In conclusion, in spite of a high prevalence of impaired
proximal accommodation and delayed gastric emptying in
FD patients, the lack of correlation between chronic upper
abdominal sensations and gastric function questions the
role of these pathophysiologic mechanisms in the genera-
tion of symptoms. Consequently, gastric function does not
serve as a clear marker for the symptoms experienced by
FD patients in daily life, and limited effect on symptoms
may be expected when targeting these speciﬁc mecha-
nisms. Finally, despite many efforts, no (measurable)
motoric disorder can be appointed as a possible patho-
physiologic mechanism underlying the presence of upper
abdominal symptoms. Most likely, other factors like vis-
ceral perception play a vital role in functional dyspepsia.
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(all P[0.01)
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